Novartis Ag (NVS) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $0.72.
- Novartis Ag's Debt to Equity rose 741.03% to $0.72 in Q4 2025 from the same period last year, while for Dec 2025 it was $0.72, marking a year-over-year increase of 741.03%. This contributed to the annual value of $0.72 for FY2025, which is 741.03% up from last year.
- Latest data reveals that Novartis Ag reported Debt to Equity of $0.72 as of Q4 2025, which was up 741.03% from $38.47 recorded in Q1 2025.
- In the past 5 years, Novartis Ag's Debt to Equity ranged from a high of $39.33 in Q1 2021 and a low of $0.43 during Q4 2021
- In the last 5 years, Novartis Ag's Debt to Equity had a median value of $31.53 in 2023 and averaged $19.5.
- In the last 5 years, Novartis Ag's Debt to Equity crashed by 3173.41% in 2021 and then skyrocketed by 2741.49% in 2024.
- Quarter analysis of 5 years shows Novartis Ag's Debt to Equity stood at $0.43 in 2021, then rose by 2.32% to $0.44 in 2022, then rose by 19.51% to $0.53 in 2023, then increased by 27.41% to $0.67 in 2024, then rose by 7.41% to $0.72 in 2025.
- Its Debt to Equity was $0.72 in Q4 2025, compared to $38.47 in Q1 2025 and $0.67 in Q4 2024.